openPR Logo
Press release

Why the Biomarkers Market is set to explode? Top Companies: Abbott, R&D System, F. Hoffmann-La Roche Ltd., R&D System, Thermo Fisher Scientific, Axon Medchem, Bio-Rad, Laboratories, Inc., BioVision Inc., Sino Biological Inc., CENTOGENE N.V., Other key mar

03-16-2020 11:42 AM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd.

Why the Biomarkers Market is set to explode? Top Companies:

The global "biomarkers" market is set to gain traction from their increasing usage in a wide variety of applications, namely, drug discovery and development, safety assessment, and medicine. Besides, numerous biotech and pharmaceutical companies are persistently investing huge sums in the research and development activities. The increasing prevalence of cancer is also one of the crucial factors that would affect the market positively during the forecast period.

The above information is given by Fortune Business Insights(TM) in a recent study, titled, "Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026." The study further mentions that the biomarker market size was USD 39.10 billion in 2018 and is projected to reach USD 97.51 billion by 2026, thereby exhibiting a CAGR of 12.1% during the forecast period.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/biomarkers-market-102173

Key Players Operating in The Biomarkers MarketInclude:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
o Abbott
o R&D System
o F. Hoffmann-La Roche Ltd.
o R&D System
o Thermo Fisher Scientific
o Axon Medchem
o Bio-Rad Laboratories, Inc.
o BioVision Inc.
o Sino Biological Inc.
o CENTOGENE N.V.
o Other key market players

Highlights of the Report:

o In-depth analysis of various insights, namely, Biomarkers Markettrends, growth drivers, opportunities, and other related challenges.
o Comprehensive details of key market players, their core competencies, and Biomarkers Marketshare.
o The potency of suppliers and buyers to make better business decisions.
o Lists out the market size in terms of volume.

Increasing Demand for Personalized Medicine to Accelerate Growth

Biomarkers are increasingly used in disease diagnostics. They also play an important role in development of personalized medicine for several disease conditions. Disease diagnosis and treatment procedures possess certain limitations and because of this, the concept of personalized medicine is becoming popular nowadays. Patients suffering from immunological disorders and cancer are rapidly inclining towards customized treatment options based on their genetic and clinical features. It would propel the biomarkers market growth during the forecast period.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/biomarkers-market-102173

Oncology Segment to Grow Steadily Backed by Rising Prevalence of Chronic Diseases
In terms of indication, the market is grouped into oncology, cardiology, neurology and others. Out of these, the oncology segment dominated the market in 2018. This growth is attributable to the increasing cases of cancer. Growing demand for personalized medicine in diagnosis and treatment of cancer, along with increasing number of new biomarker based assays and tests being introduced by market players, is propelling the growth of oncology segment. Rising prevalence of neurological disorders and increasing investment by key market players in the development of neurology biomarkers are is one of the major factor anticipated to drive the growth of the segment at faster rate.

Detailed Table of Content:

o Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
o Executive Summary
o Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
o Key Insights
o New Product Launches, by Key Market Players
o Prevalence by Disease Indication, By Key Countries/ Region, 2018
o Incidence of Cancer, By Key Countries/ Key Region,2018
o Key industry Developments - Mergers, Acquisitions and Partnerships
o Overview of Biomarkers In Personalized Medicine
o Global Biomarkers Market Analysis, Insights and Forecast, 2015-2026
o Key Findings / Summary
o Market Analysis, Insights and Forecast - By Indication
? Oncology
? Cardiology
? Neurology
? Others
o Market Analysis, Insights and Forecast - By End User
? Pharmaceutical & Biotechnology Companies
? Diagnostics & Research Laboratories
? Hospitals & Specialty Clinics
? Others
o Market Analysis, Insights and Forecast - By Region
? North America
? Europe
? Asia Pacific
? Latin America
? Middle East & Africa
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/biomarkers-market-102173

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Why the Biomarkers Market is set to explode? Top Companies: Abbott, R&D System, F. Hoffmann-La Roche Ltd., R&D System, Thermo Fisher Scientific, Axon Medchem, Bio-Rad, Laboratories, Inc., BioVision Inc., Sino Biological Inc., CENTOGENE N.V., Other key mar here

News-ID: 1968661 • Views:

More Releases from Fortune Business Insights Pvt. Ltd.

Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% CAGR During the Forecast Period
Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% …
The global bread maker market size was valued at USD 7.48 billion in 2023 and is expected to be worth USD 7.70 billion in 2024. The market is projected to reach USD 11.13 billion by 2032, recording a CAGR of 4.71% during the forecast period. Bread maker machines enable users to create a diverse range of bread at home cost-effectively. The increasing demand for innovative home appliances and the rising replacement
Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Forecast Period.
Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Foreca …
The global streetwear market size was valued at USD 325.28 billion in 2023. The market is projected to be worth USD 347.14 billion in 2024 and reach USD 637.13 billion by 2032, exhibiting a CAGR of 7.89% during the forecast period. Asia Pacific dominated the streetwear market with a market share of 36.17% in 2023. Fortune Business InsightsTM displays this information in a report titled, "Streetwear Market, 2024-2032." Request a Free Sample
Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Companies- Nike, Supreme, Stussy, BAPE
Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Compan …
The streetwear market size was valued at USD 325.28 billion in 2023 and is expected to be worth USD 347.14 billion in 2024. The market is projected to reach USD 637.13 billion by 2032, recording a CAGR of 7.89% during the forecast period. Streetwear is youth-inspired clothing that is highly popular among hip-hop enthusiasts and skateboarders. It is popular for its vibrant colors, bold logo graphics, and unconventional designs. Streetwear is
Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- L'Oréal S.A.( France), Unilever Plc (U.K.), Coty Inc. (U.S.)
Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- …
The global perfume market size was valued at USD 48.05 billion in 2023 and is projected to grow from USD 50.45 billion in 2024 to USD 77.52 billion by 2032, exhibiting a CAGR of 5.51% during the forecast period. Perfumes are pleasant smelling solutions made by using oils, fragrances, and other ingredients to create a pleasing aroma. Increasing demand for high-quality beauty and grooming products globally is expected to boost the

All 5 Releases


More Releases for Biomarkers

Biomarkers Market Soars: Safety Biomarkers Lead with 15.9% Projected Growth from …
The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022-2032. Biomarkers, or biological indicators, have revolutionized the fields of medicine and healthcare by enabling early disease detection, personalized treatment, and
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040 This latest report researches the industry structure, sales, revenue,
Cardiac Biomarkers Market - Unveiling Heart Health: Biomarkers Revolutionizing C …
Newark, New Castle, USA: The "Cardiac Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Biomarkers Market: https://www.growthplusreports.com/report/cardiac-biomarkers-market/8024 This latest report researches the industry structure, sales, revenue,
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out